FDAnews Drug Daily Bulletin

FDA Issues Enforcement Action Based on Non-FDA Inspection

Aug. 14, 2012
International cooperation between regulators is “taking off” — a trend that could limit the amount of duplicate inspections drugmakers face, a top CDER official says. While “mutual recognition” of inspections is not yet a reality, drugmakers shouldn’t expect the FDA to close its eyes to negative inspection findings from other regulators.
Drug GMP Report